Seth Lederman

Seth Lederman

Amministratore Delegato presso TONIX PHARMACEUTICALS HOLDING CORP.

Patrimonio netto: 357 656 $ in data 31/05/2026

68 anni
Health Technology
Consumer Services
Finance

Profilo

Seth Lederman founded Ivrea Pharmaceuticals, Inc. in 2005, Tonix Pharmaceuticals, Inc. in 2007, where he is working as Chairman & President from 2010, Tonix Pharmaceuticals Holding Corp.
in 2007, where he is working as Chairman, President & Chief Executive Officer from 2011, and various other companies.
Dr. Lederman also founded Validus LLC, where he worked as Chairman and Vela Pharmaceuticals, Inc., where he worked as Chairman from 2007 to 2008.
Dr. Lederman also currently works at Starling Pharmaceuticals, Inc., as Chairman & Chief Executive Officer from 2011, Krele LLC, as Chairman from 2010, Tonix Pharmaceuticals (Canada), Inc., as President & Director from 2013, and various other companies.
Dr. Lederman also formerly worked at Tamandare Explorations, Inc., as Chairman, President & Chief Executive Officer in 2011, Leder Laboratories, Inc., as Chairman & Chief Executive Officer from 2011 to 2018, Validus Pharmaceuticals LLC, as Chairman from 2007 to 2008, and various other companies.
Dr. Lederman received his undergraduate degree in 1979 from Princeton University and doctorate degree in 1983 from Columbia University College of Physicians & Surgeons.

Partecipazioni note in società pubbliche

SocietàDataNumero di azioniValutazioneData di valutazione
09/06/2026 29.007 ( 0,25% ) 357 656 $ 31/05/2026

Posizioni attive di Seth Lederman

SocietàPosizioneInizio
TONIX PHARMACEUTICALS HOLDING CORP. Amministratore Delegato 16/11/2007
Tonix Pharmaceuticals (Canada), Inc.
Presidente 01/04/2013
Starling Pharmaceuticals, Inc.
Amministratore Delegato 01/12/2011
Lederman Seth Co. LLC
Corporate Officer/Principal 01/01/2007
Presidente 16/08/2010
Fondatore 07/06/2007

Precedenti posizioni note di Seth Lederman

SocietàPosizioneFine
L&L Technologies, Inc.
Corporate Officer/Principal 01/03/2025
Plumbline LLC
Corporate Officer/Principal 01/03/2025
Lederman & Co. LLC
Corporate Officer/Principal 01/03/2025
░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░░░ ░░░░░░░░░░
░░░ ░░░░░░░░ ░░ ░░░░░░░░ ░░░░░░░░░░ ░░ ░░░ ░░░░ ░░ ░░░ ░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
Vedi nel dettaglio l'esperienza di Seth Lederman

Formazione di Seth Lederman

Esperienze
Posizioni ricoperte

Attive

Inattive

Società nel listino

Aziende private

Relazioni

60

Relazioni di 1° grado

28

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Società collegate

Aziende private28

Health Technology

Health Technology

Retail Trade

Non-Energy Minerals

Health Technology

Consumer Services

Consumer Services

Commercial Services

Health Technology

Targent Pharmaceuticals LLC

Lederman & Co. LLC

L&L Technologies, Inc.

Health Technology

Plumbline LLC

Validus LLC

Lederman Seth Co. LLC

Leder Laboratories, Inc.

Starling Pharmaceuticals, Inc.

Consumer Services

Tonix Pharmaceuticals (Canada), Inc.

Tonix Pharmaceuticals (Barbados) Ltd.

Health Technology

Tonix Pharma Holdings Ltd.

Fontus Pharmaceuticals, Inc.

Finance

Finance

Konanda General Partner LLC

  1. Mercati
  2. Insiders
  3. Seth Lederman
- 40%: I migliori strumenti riservati agli abbonati per individuare le opportunità di investimento di domani.
g
:
:
ENTRA ORA